z-logo
Premium
Fluorine‐18 labelling of a series of potential EGFRvIII targeting peptides with a parallel labelling approach using [ 18 F]FPyME
Author(s) -
Denholt Charlotte L.,
Kuhnast Bertrand,
Dollé Frédéric,
Hinnen Francoise,
Hansen Paul R.,
Gillings Nic,
Kjær Andreas
Publication year - 2010
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.1795
Subject(s) - labelling , chemistry , peptide , yield (engineering) , epidermal growth factor receptor , combinatorial chemistry , stereochemistry , radiochemistry , receptor , biochemistry , materials science , metallurgy
There is growing interest in the use of radiolabelled peptides as receptor targeting agents for diagnostic imaging of various cancer types using positron emission tomography. In this work, 1‐[3‐(2‐[ 18 F]fluoropyridin‐3‐yloxy)propyl]pyrrole‐2,5‐dione ([ 18 F]FPyME) has been used for parallel fluorine‐18 labelling of PEPHC1, a peptide selective towards the cancer‐specific mutation of the epidermal growth factor receptor (EGFRvIII), and a number of truncated and mutated analogues. Conjugation of the peptides with [ 18 F]FPyME was achieved within 10 min in non‐decay‐corrected radiochemical yields of 30–50%. The high yield of the conjugation reaction combined with its short synthesis time allows the labelling of several peptides from a single batch of [ 18 F]FPyME. Copyright © 2010 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom